Fagron NV (OTCMKTS:ARSUF) Short Interest Down 31.8% in December

Fagron NV (OTCMKTS:ARSUF) was the target of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling 6,334 shares, a drop of 31.8% from the November 30th total of 9,294 shares. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days. Based on an average daily volume of 0 shares, the short-interest ratio is currently ∞ days.

Fagron Stock Performance

OTCMKTS ARSUF opened at $23.50 on Monday. Fagron has a 12 month low of $23.50 and a 12 month high of $23.66. The stock has a 50-day simple moving average of $23.50 and a 200 day simple moving average of $24.32.

Fagron Company Profile

Fagron (OTCMKTS:ARSUF) is a global pharmaceutical compounding company that supplies raw materials, equipment and services to compounding pharmacies, hospitals and healthcare practitioners. Its portfolio encompasses a range of pharmaceutical ingredients, dosage forms and specialized compounding solutions designed to meet patient-specific needs. The company supports the preparation of customized medications in areas such as dermatology, pain management, hormone replacement therapy and veterinary medicine, providing both sterile and non-sterile compounding products.

Headquartered in Rotterdam, the Netherlands, Fagron operates in more than 55 countries across Europe, the Americas, Asia-Pacific and the Middle East & Africa.